According to legal filings and public reports, the severe side effects of Ozempic that were not properly addressed on past warning labels include: Vision loss (caused by NAION, a type of eye stroke) Gastrointestinal issues (e.g., ileus, gastroparesis, and bowel obstructions) Gallbladder problems Pancreatitis Blood clots and deep vein thrombosis Multiple scientific studies have suggested that these side effects, while relatively uncommon, may be more likely to occur if a patient is taking Ozempic or another GLP-1 drug compared to some other common diabetes drugs
Always consult qualified healthcare providers before starting any new therapy
The first reaction is the formation of the dipeptide -glutamylcysteine (GGC) from the amino acids L-glutamic acid and L-cysteine
James LP, Mayeux PR, Hinson JA
2 Synthetic GLP-1RAs are structurally modified analogues engineered to resist dipeptidyl peptidase-4 cleavage, prolonging their half-life
The absence of a preexisting obesity diagnosis or any previous anti-obesity drug further acted as surrogate markers for potential off-label prescribing of the GLP-1 RA brand with the indication of obesity